The TRAfermin in Neuropathic Diabetic Foot Ulcer Study - Northern Europe The TRANS-North Study
Clinical trial NCT01217476 · COMPLETED
Trial details
- NCT number
- NCT01217476
- Sponsor
- Olympus Biotech Corporation
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-12-01
- Primary completion
- 2012-05-01
- Enrollment
- 207
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.